Cetera Investment Advisers’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $253M | Buy |
1,034,600
+10,644
| +1% | +$2.48M | 0.27% | 65 |
|
|
2025
Q4 | $212M | Buy |
1,023,956
+68,118
| +7% | +$13.5M | 0.23% | 81 |
|
|
2025
Q3 | $177M | Buy |
955,838
+241,415
| +34% | +$41.4M | 0.21% | 91 |
|
|
2025
Q2 | $109M | Buy |
714,423
+5,450
| +0.8% | +$838K | 0.18% | 104 |
|
|
2025
Q1 | $118M | Buy |
708,973
+52,988
| +8% | +$8.29M | 0.23% | 90 |
|
|
2024
Q4 | $94.9M | Buy |
655,985
+11,459
| +2% | +$1.78M | 0.2% | 98 |
|
|
2024
Q3 | $104M | Sell |
644,526
-7,504
| -1% | -$1.2M | 0.23% | 87 |
|
|
2024
Q2 | $95.3M | Sell |
652,030
-55,243
| -8% | -$8.22M | 0.22% | 89 |
|
|
2024
Q1 | $112M | Buy |
707,273
+488,955
| +224% | +$77.8M | 0.26% | 73 |
|
|
2023
Q4 | $34.2M | Sell |
218,318
-3,405
| -2% | -$522K | 0.28% | 68 |
|
|
2023
Q3 | $34.5M | Sell |
221,723
-2,422
| -1% | -$400K | 0.3% | 60 |
|
|
2023
Q2 | $37.1M | Sell |
224,145
-882
| -0.4% | -$142K | 0.31% | 54 |
|
|
2023
Q1 | $34.9M | Buy |
225,027
+5,587
| +3% | +$902K | 0.3% | 51 |
|
|
2022
Q4 | $38.8M | Buy |
219,440
+71,737
| +49% | +$12.4M | 0.36% | 47 |
|
|
2022
Q3 | $24.1M | Sell |
147,703
-38,163
| -21% | -$6.46M | 0.48% | 29 |
|
|
2022
Q2 | $33M | Buy |
185,866
+20,224
| +12% | +$3.6M | 0.52% | 30 |
|
|
2022
Q1 | $29.4M | Buy |
165,642
+4,020
| +2% | +$684K | 0.42% | 39 |
|
|
2021
Q4 | $27.6M | Buy |
161,622
+3,287
| +2% | +$538K | 0.4% | 46 |
|
|
2021
Q3 | $25.6M | Buy |
158,335
+909
| +0.6% | +$155K | 0.41% | 43 |
|
|
2021
Q2 | $25.9M | Buy |
157,426
+13,366
| +9% | +$2.21M | 0.42% | 41 |
|
|
2021
Q1 | $23.7M | Sell |
144,060
-4,487
| -3% | -$726K | 0.47% | 39 |
|
|
2020
Q4 | $23.4M | Buy |
148,547
+106,404
| +252% | +$15.7M | 0.46% | 37 |
|
|
2020
Q3 | $6.27M | Buy |
42,143
+2,901
| +7% | +$429K | 0.51% | 38 |
|
|
2020
Q2 | $5.52M | Buy |
39,242
+3,522
| +10% | +$513K | 0.51% | 40 |
|
|
2020
Q1 | $4.68M | Buy |
35,720
+2,071
| +6% | +$294K | 0.57% | 39 |
|
|
2019
Q4 | $4.91M | Buy |
33,649
+1,025
| +3% | +$139K | 0.49% | 50 |
|
|
2019
Q3 | $4.22M | Sell |
32,624
-1,166
| -3% | -$154K | 0.51% | 47 |
|
|
2019
Q2 | $4.71M | Buy |
33,790
+1,580
| +5% | +$219K | 0.61% | 35 |
|
|
2019
Q1 | $4.5M | Buy |
32,210
+152
| +0.5% | +$20.4K | 0.64% | 35 |
|
|
2018
Q4 | $4.13M | Sell |
32,058
-2,969
| -8% | -$414K | 0.67% | 32 |
|
|
2018
Q3 | $4.84M | Buy |
35,027
+1,949
| +6% | +$259K | 0.7% | 27 |
|
|
2018
Q2 | $4.01M | Sell |
33,078
-3,408
| -9% | -$425K | 0.7% | 28 |
|
|
2018
Q1 | $4.68M | Sell |
36,486
-1,923
| -5% | -$260K | 0.88% | 19 |
|
|
2017
Q4 | $5.36M | Buy |
38,409
+1,359
| +4% | +$189K | 0.98% | 18 |
|
|
2017
Q3 | $4.83M | Buy |
37,050
+4,243
| +13% | +$562K | 1.07% | 15 |
|
|
2017
Q2 | $4.33M | Buy |
32,807
+345
| +1% | +$44K | 1.06% | 15 |
|
|
2017
Q1 | $4.03M | Buy |
32,462
+1,828
| +6% | +$218K | 1.11% | 15 |
|
|
2016
Q4 | $3.54M | Buy |
30,634
+7,223
| +31% | +$834K | 1.18% | 14 |
|
|
2016
Q3 | $2.77M | Sell |
23,411
-8,019
| -26% | -$973K | 1.19% | 17 |
|
|
2016
Q2 | $3.81M | Buy |
31,430
+2,185
| +7% | +$248K | 1.49% | 9 |
|
|
2016
Q1 | $3.16M | Buy |
29,245
+1,096
| +4% | +$113K | 1.37% | 11 |
|
|
2015
Q4 | $2.89M | Buy |
+28,149
| New | +$2.83M | 1.33% | 14 |
|
Other funds holding JNJ
VCM
VPM
Cetera Investment Advisers's JNJ Position: Q1 2026 in Review
Cetera Investment Advisers increased its Johnson & Johnson (JNJ) stake by 1% in Q1 2026, buying an estimated $2.48M and bringing the position to 1,034,600 shares worth $253M. The position accounts for 0.27% of the portfolio, ranked #65.
Cetera Investment Advisers first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Cetera Investment Advisers held 1,034,600 shares of Johnson & Johnson worth $253M as of Q1 2026.
- Cetera Investment Advisers bought 10,644 Johnson & Johnson shares in Q1 2026, an estimated $2.48M.
- Johnson & Johnson made up 0.27% of Cetera Investment Advisers's portfolio in Q1 2026, its #65 holding.
- Cetera Investment Advisers first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.